DENVER, Sept. 09, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ:NTHI) is entering a potentially important new phase with fresh institutional capital, encouraging Phase 2a data and a string of open-market insider purchases. The company announced a $15 million registered direct offering priced at-the-market under Nasdaq rules, involving new and existing healthcare-focused institutional investors. The deal includes 3.57 million shares, or pre-funded warrants in lieu of shares, plus warrants covering another 3.57 million shares at a $4.20 exercise price. Closing is expected tomorrow, subject to customary conditions.
Read more at globenewswire.com
